AMLX
Price
$3.51
Change
-$0.27 (-7.14%)
Updated
Apr 3 closing price
Capitalization
310.99M
34 days until earnings call
ATYR
Price
$2.79
Change
-$0.17 (-5.74%)
Updated
Apr 3 closing price
Capitalization
247.03M
33 days until earnings call
Ad is loading...

AMLX vs ATYR

Header iconAMLX vs ATYR Comparison
Open Charts AMLX vs ATYRBanner chart's image
Amylyx Pharmaceuticals
Price$3.51
Change-$0.27 (-7.14%)
Volume$721.36K
Capitalization310.99M
aTyr Pharma
Price$2.79
Change-$0.17 (-5.74%)
Volume$1.49M
Capitalization247.03M
AMLX vs ATYR Comparison Chart
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. ATYR commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a StrongBuy and ATYR is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (AMLX: $3.51 vs. ATYR: $2.78)
Brand notoriety: AMLX and ATYR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 91% vs. ATYR: 100%
Market capitalization -- AMLX: $310.99M vs. ATYR: $247.03M
AMLX [@Biotechnology] is valued at $310.99M. ATYR’s [@Biotechnology] market capitalization is $247.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileATYR’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • ATYR’s FA Score: 0 green, 5 red.
According to our system of comparison, AMLX is a better buy in the long-term than ATYR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 6 TA indicator(s) are bullish while ATYR’s TA Score has 4 bullish TA indicator(s).

  • AMLX’s TA Score: 6 bullish, 2 bearish.
  • ATYR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than ATYR.

Price Growth

AMLX (@Biotechnology) experienced а -9.30% price change this week, while ATYR (@Biotechnology) price change was -14.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.89%. For the same industry, the average monthly price growth was -11.08%, and the average quarterly price growth was -14.87%.

Reported Earning Dates

AMLX is expected to report earnings on May 08, 2025.

ATYR is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-8.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX($311M) has a higher market cap than ATYR($247M). AMLX YTD gains are higher at: -7.143 vs. ATYR (-22.928). ATYR has higher annual earnings (EBITDA): -66.37M vs. AMLX (-290.98M). AMLX has more cash in the bank: 177M vs. ATYR (72.1M). AMLX has less debt than ATYR: AMLX (1.98M) vs ATYR (13.3M). AMLX has higher revenues than ATYR: AMLX (87.4M) vs ATYR (235K).
AMLXATYRAMLX / ATYR
Capitalization311M247M126%
EBITDA-290.98M-66.37M438%
Gain YTD-7.143-22.92831%
P/E Ratio2.69N/A-
Revenue87.4M235K37,191%
Total Cash177M72.1M245%
Total Debt1.98M13.3M15%
FUNDAMENTALS RATINGS
ATYR: Fundamental Ratings
ATYR
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXATYR
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 9 days ago
76%
Bullish Trend 23 days ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ATYR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FSEKX12.04N/A
N/A
Fidelity Advisor Sustainable U.S. Eq A
DFSIX43.65N/A
N/A
DFA US Sustainability Core 1
SCIUX10.94N/A
N/A
Invesco Income Advantage U.S. Fund R5
NWJEX98.38N/A
N/A
Nationwide NYSE Arca Tech 100 Idx R6
AEGMX11.51N/A
N/A
American Century Emerging Markets R5

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-7.14%
XOMAO - AMLX
68%
Closely correlated
+1.46%
IKNA - AMLX
54%
Loosely correlated
-4.00%
XOMAP - AMLX
51%
Loosely correlated
+0.90%
JAZZ - AMLX
43%
Loosely correlated
-4.44%
RGNX - AMLX
43%
Loosely correlated
-5.39%
More

ATYR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with MGTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then MGTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATYR
1D Price
Change %
ATYR100%
-5.74%
MGTX - ATYR
43%
Loosely correlated
-3.62%
NTLA - ATYR
36%
Loosely correlated
-5.62%
SLDB - ATYR
35%
Loosely correlated
-7.72%
ARWR - ATYR
35%
Loosely correlated
-4.96%
AMLX - ATYR
34%
Loosely correlated
-7.14%
More